NantHealth, Inc.
NantHealth, Inc. NHIQ Peers
See (NHIQ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NHIQ | $0.00 | N/A | 82414.00 | N/A | -$7.73 | N/A |
| PMCUF | $170.06 | +4.52% | 17.76B | 283.43 | $0.60 | +0.11% |
| MTHRY | $6.49 | -0.95% | 8.82B | 32.46 | $0.20 | N/A |
| MTHRF | $12.95 | +26.96% | 8.79B | 31.59 | $0.41 | +0.01% |
| PANHF | $0.96 | +11.73% | 2.08B | 96.20 | $0.01 | +129.58% |
| CMPUY | $24.63 | +40.31% | 1.27B | 41.74 | $0.59 | +4.34% |
| PIAHY | $2.29 | N/A | 1.24B | 114.50 | $0.02 | +217.08% |
| CMPVF | $23.85 | +0.02% | 1.23B | 40.43 | $0.59 | +5.07% |
| RSLBF | $32.19 | +56.24% | 1.10B | 52.76 | $0.61 | +0.58% |
| CRWRF | $24.28 | N/A | 850.27M | 57.81 | $0.42 | +1.56% |
Stock Comparison
NHIQ vs PMCUF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PMCUF has a market cap of 17.76B. Regarding current trading prices, NHIQ is priced at $0.00, while PMCUF trades at $170.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PMCUF's P/E ratio is 283.43. In terms of profitability, NHIQ's ROE is +0.35%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, NHIQ is more volatile compared to PMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MTHRY Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MTHRY has a market cap of 8.82B. Regarding current trading prices, NHIQ is priced at $0.00, while MTHRY trades at $6.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MTHRY's P/E ratio is 32.46. In terms of profitability, NHIQ's ROE is +0.35%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, NHIQ is more volatile compared to MTHRY. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MTHRF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MTHRF has a market cap of 8.79B. Regarding current trading prices, NHIQ is priced at $0.00, while MTHRF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MTHRF's P/E ratio is 31.59. In terms of profitability, NHIQ's ROE is +0.35%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, NHIQ is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PANHF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PANHF has a market cap of 2.08B. Regarding current trading prices, NHIQ is priced at $0.00, while PANHF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PANHF's P/E ratio is 96.20. In terms of profitability, NHIQ's ROE is +0.35%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, NHIQ is more volatile compared to PANHF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CMPUY Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CMPUY has a market cap of 1.27B. Regarding current trading prices, NHIQ is priced at $0.00, while CMPUY trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CMPUY's P/E ratio is 41.74. In terms of profitability, NHIQ's ROE is +0.35%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, NHIQ is more volatile compared to CMPUY. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PIAHY Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PIAHY has a market cap of 1.24B. Regarding current trading prices, NHIQ is priced at $0.00, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PIAHY's P/E ratio is 114.50. In terms of profitability, NHIQ's ROE is +0.35%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, NHIQ is more volatile compared to PIAHY. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CMPVF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CMPVF has a market cap of 1.23B. Regarding current trading prices, NHIQ is priced at $0.00, while CMPVF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CMPVF's P/E ratio is 40.43. In terms of profitability, NHIQ's ROE is +0.35%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, NHIQ is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs RSLBF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, RSLBF has a market cap of 1.10B. Regarding current trading prices, NHIQ is priced at $0.00, while RSLBF trades at $32.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas RSLBF's P/E ratio is 52.76. In terms of profitability, NHIQ's ROE is +0.35%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, NHIQ is less volatile compared to RSLBF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CRWRF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CRWRF has a market cap of 850.27M. Regarding current trading prices, NHIQ is priced at $0.00, while CRWRF trades at $24.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CRWRF's P/E ratio is 57.81. In terms of profitability, NHIQ's ROE is +0.35%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, NHIQ is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SMSZF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SMSZF has a market cap of 727.28M. Regarding current trading prices, NHIQ is priced at $0.00, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SMSZF's P/E ratio is 17.47. In terms of profitability, NHIQ's ROE is +0.35%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, NHIQ is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SUSRF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SUSRF has a market cap of 643.95M. Regarding current trading prices, NHIQ is priced at $0.00, while SUSRF trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SUSRF's P/E ratio is 46.74. In terms of profitability, NHIQ's ROE is +0.35%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, NHIQ is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs KSIOF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, KSIOF has a market cap of 448.76M. Regarding current trading prices, NHIQ is priced at $0.00, while KSIOF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas KSIOF's P/E ratio is -237.70. In terms of profitability, NHIQ's ROE is +0.35%, compared to KSIOF's ROE of -0.20%. Regarding short-term risk, NHIQ is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs VHIBF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, VHIBF has a market cap of 415.20M. Regarding current trading prices, NHIQ is priced at $0.00, while VHIBF trades at $7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas VHIBF's P/E ratio is 256.33. In terms of profitability, NHIQ's ROE is +0.35%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, NHIQ is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SMDCF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SMDCF has a market cap of 280.87M. Regarding current trading prices, NHIQ is priced at $0.00, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, NHIQ's ROE is +0.35%, compared to SMDCF's ROE of N/A. Regarding short-term risk, NHIQ is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs DLHTF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, DLHTF has a market cap of 254.80M. Regarding current trading prices, NHIQ is priced at $0.00, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, NHIQ's ROE is +0.35%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, NHIQ is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs VPAHF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, VPAHF has a market cap of 188.24M. Regarding current trading prices, NHIQ is priced at $0.00, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, NHIQ is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs COGZF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, COGZF has a market cap of 150.20M. Regarding current trading prices, NHIQ is priced at $0.00, while COGZF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas COGZF's P/E ratio is 22.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, NHIQ is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ONVVF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ONVVF has a market cap of 137.60M. Regarding current trading prices, NHIQ is priced at $0.00, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, NHIQ is more volatile compared to ONVVF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ACMLF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ACMLF has a market cap of 130.74M. Regarding current trading prices, NHIQ is priced at $0.00, while ACMLF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ACMLF's P/E ratio is 30.33. In terms of profitability, NHIQ's ROE is +0.35%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, NHIQ is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CSAMF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CSAMF has a market cap of 98.80M. Regarding current trading prices, NHIQ is priced at $0.00, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, NHIQ's ROE is +0.35%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, NHIQ is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MDPEF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MDPEF has a market cap of 61.32M. Regarding current trading prices, NHIQ is priced at $0.00, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MDPEF's P/E ratio is 6.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to MDPEF's ROE of N/A. Regarding short-term risk, NHIQ is less volatile compared to MDPEF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HITC Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HITC has a market cap of 52.84M. Regarding current trading prices, NHIQ is priced at $0.00, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HITC's P/E ratio is -14.75. In terms of profitability, NHIQ's ROE is +0.35%, compared to HITC's ROE of -1.29%. Regarding short-term risk, NHIQ is more volatile compared to HITC. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CMHSF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CMHSF has a market cap of 43.39M. Regarding current trading prices, NHIQ is priced at $0.00, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CMHSF's P/E ratio is 18.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, NHIQ is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs RQHTF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, RQHTF has a market cap of 29.71M. Regarding current trading prices, NHIQ is priced at $0.00, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas RQHTF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, NHIQ is less volatile compared to RQHTF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs VASO Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, VASO has a market cap of 24.60M. Regarding current trading prices, NHIQ is priced at $0.00, while VASO trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas VASO's P/E ratio is 14.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to VASO's ROE of +0.04%. Regarding short-term risk, NHIQ is more volatile compared to VASO. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs RTNXF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, RTNXF has a market cap of 22.55M. Regarding current trading prices, NHIQ is priced at $0.00, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, NHIQ's ROE is +0.35%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, NHIQ is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HDSLF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HDSLF has a market cap of 21.13M. Regarding current trading prices, NHIQ is priced at $0.00, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, NHIQ's ROE is +0.35%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, NHIQ is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs TREIF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, TREIF has a market cap of 19.07M. Regarding current trading prices, NHIQ is priced at $0.00, while TREIF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas TREIF's P/E ratio is -2.74. In terms of profitability, NHIQ's ROE is +0.35%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, NHIQ is more volatile compared to TREIF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs DGNOF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, DGNOF has a market cap of 17.83M. Regarding current trading prices, NHIQ is priced at $0.00, while DGNOF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas DGNOF's P/E ratio is -5.83. In terms of profitability, NHIQ's ROE is +0.35%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, NHIQ is more volatile compared to DGNOF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs THKKF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, THKKF has a market cap of 17.81M. Regarding current trading prices, NHIQ is priced at $0.00, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas THKKF's P/E ratio is -1.51. In terms of profitability, NHIQ's ROE is +0.35%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, NHIQ is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs UDOCF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, UDOCF has a market cap of 15.26M. Regarding current trading prices, NHIQ is priced at $0.00, while UDOCF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas UDOCF's P/E ratio is -3.33. In terms of profitability, NHIQ's ROE is +0.35%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, NHIQ is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MNNDF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MNNDF has a market cap of 14.25M. Regarding current trading prices, NHIQ is priced at $0.00, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, NHIQ's ROE is +0.35%, compared to MNNDF's ROE of N/A. Regarding short-term risk, NHIQ is more volatile compared to MNNDF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CRVW Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CRVW has a market cap of 13.68M. Regarding current trading prices, NHIQ is priced at $0.00, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CRVW's P/E ratio is -2.34. In terms of profitability, NHIQ's ROE is +0.35%, compared to CRVW's ROE of +0.12%. Regarding short-term risk, NHIQ is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs AIMLF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, AIMLF has a market cap of 13.42M. Regarding current trading prices, NHIQ is priced at $0.00, while AIMLF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas AIMLF's P/E ratio is -1.93. In terms of profitability, NHIQ's ROE is +0.35%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, NHIQ is more volatile compared to AIMLF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PBSV Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PBSV has a market cap of 9.86M. Regarding current trading prices, NHIQ is priced at $0.00, while PBSV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PBSV's P/E ratio is -21.51. In terms of profitability, NHIQ's ROE is +0.35%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, NHIQ is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HSCHF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HSCHF has a market cap of 9.50M. Regarding current trading prices, NHIQ is priced at $0.00, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HSCHF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs VYND Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, VYND has a market cap of 9.16M. Regarding current trading prices, NHIQ is priced at $0.00, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas VYND's P/E ratio is -24.99. In terms of profitability, NHIQ's ROE is +0.35%, compared to VYND's ROE of +0.48%. Regarding short-term risk, NHIQ is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HBCNF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HBCNF has a market cap of 8.44M. Regarding current trading prices, NHIQ is priced at $0.00, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, NHIQ's ROE is +0.35%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, NHIQ is more volatile compared to HBCNF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SPLTF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SPLTF has a market cap of 7.95M. Regarding current trading prices, NHIQ is priced at $0.00, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, NHIQ's ROE is +0.35%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, NHIQ is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EMOR Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EMOR has a market cap of 7.55M. Regarding current trading prices, NHIQ is priced at $0.00, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EMOR's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, NHIQ is more volatile compared to EMOR. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CRBKF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CRBKF has a market cap of 6.84M. Regarding current trading prices, NHIQ is priced at $0.00, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, NHIQ's ROE is +0.35%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, NHIQ is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs DOCRF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, DOCRF has a market cap of 6.25M. Regarding current trading prices, NHIQ is priced at $0.00, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, NHIQ's ROE is +0.35%, compared to DOCRF's ROE of -1.25%. Regarding short-term risk, NHIQ is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MDBIF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MDBIF has a market cap of 5.12M. Regarding current trading prices, NHIQ is priced at $0.00, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MDBIF's P/E ratio is -0.21. In terms of profitability, NHIQ's ROE is +0.35%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, NHIQ is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CNONF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CNONF has a market cap of 4.99M. Regarding current trading prices, NHIQ is priced at $0.00, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CNONF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, NHIQ is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs RYAHF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, RYAHF has a market cap of 4.96M. Regarding current trading prices, NHIQ is priced at $0.00, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, NHIQ's ROE is +0.35%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CDXFF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CDXFF has a market cap of 4.82M. Regarding current trading prices, NHIQ is priced at $0.00, while CDXFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CDXFF's P/E ratio is -1.20. In terms of profitability, NHIQ's ROE is +0.35%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, NHIQ is more volatile compared to CDXFF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs IQAIF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, IQAIF has a market cap of 4.19M. Regarding current trading prices, NHIQ is priced at $0.00, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas IQAIF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to IQAIF's ROE of -2.26%. Regarding short-term risk, NHIQ is more volatile compared to IQAIF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CBDS Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CBDS has a market cap of 4.17M. Regarding current trading prices, NHIQ is priced at $0.00, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CBDS's P/E ratio is -1.46. In terms of profitability, NHIQ's ROE is +0.35%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, NHIQ is more volatile compared to CBDS. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CMPD Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CMPD has a market cap of 3.79M. Regarding current trading prices, NHIQ is priced at $0.00, while CMPD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CMPD's P/E ratio is -13.04. In terms of profitability, NHIQ's ROE is +0.35%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, NHIQ is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MITI Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MITI has a market cap of 3.39M. Regarding current trading prices, NHIQ is priced at $0.00, while MITI trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MITI's P/E ratio is -0.71. In terms of profitability, NHIQ's ROE is +0.35%, compared to MITI's ROE of +0.15%. Regarding short-term risk, NHIQ is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EKGGF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EKGGF has a market cap of 1.97M. Regarding current trading prices, NHIQ is priced at $0.00, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EKGGF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to EKGGF's ROE of +0.45%. Regarding short-term risk, NHIQ is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EBYH Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EBYH has a market cap of 1.89M. Regarding current trading prices, NHIQ is priced at $0.00, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EBYH's P/E ratio is -5.43. In terms of profitability, NHIQ's ROE is +0.35%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, NHIQ is more volatile compared to EBYH. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs BNVIF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, BNVIF has a market cap of 1.67M. Regarding current trading prices, NHIQ is priced at $0.00, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas BNVIF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, NHIQ is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CSOC Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CSOC has a market cap of 1.59M. Regarding current trading prices, NHIQ is priced at $0.00, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CSOC's P/E ratio is 0.29. In terms of profitability, NHIQ's ROE is +0.35%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, NHIQ is more volatile compared to CSOC. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs LVCE Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, LVCE has a market cap of 1.35M. Regarding current trading prices, NHIQ is priced at $0.00, while LVCE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas LVCE's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to LVCE's ROE of N/A. Regarding short-term risk, NHIQ is more volatile compared to LVCE. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CTVEF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CTVEF has a market cap of 1.21M. Regarding current trading prices, NHIQ is priced at $0.00, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CTVEF's P/E ratio is -0.23. In terms of profitability, NHIQ's ROE is +0.35%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, NHIQ is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EVAHF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EVAHF has a market cap of 1.09M. Regarding current trading prices, NHIQ is priced at $0.00, while EVAHF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EVAHF's P/E ratio is -9.40. In terms of profitability, NHIQ's ROE is +0.35%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, NHIQ is less volatile compared to EVAHF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MDRM Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MDRM has a market cap of 1.02M. Regarding current trading prices, NHIQ is priced at $0.00, while MDRM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MDRM's P/E ratio is -0.80. In terms of profitability, NHIQ's ROE is +0.35%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, NHIQ is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PPJE Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PPJE has a market cap of 920484.00. Regarding current trading prices, NHIQ is priced at $0.00, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PPJE's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to PPJE. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MDXL Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MDXL has a market cap of 845013.00. Regarding current trading prices, NHIQ is priced at $0.00, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MDXL's P/E ratio is -0.10. In terms of profitability, NHIQ's ROE is +0.35%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, NHIQ is more volatile compared to MDXL. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs CGNSF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, CGNSF has a market cap of 640451.00. Regarding current trading prices, NHIQ is priced at $0.00, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas CGNSF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, NHIQ is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs DTRK Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, DTRK has a market cap of 639000.00. Regarding current trading prices, NHIQ is priced at $0.00, while DTRK trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas DTRK's P/E ratio is -8.33. In terms of profitability, NHIQ's ROE is +0.35%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, NHIQ is more volatile compared to DTRK. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs NEWUF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, NEWUF has a market cap of 619319.00. Regarding current trading prices, NHIQ is priced at $0.00, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas NEWUF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, NHIQ is less volatile compared to NEWUF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ACHKF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ACHKF has a market cap of 522554.00. Regarding current trading prices, NHIQ is priced at $0.00, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ACHKF's P/E ratio is -0.07. In terms of profitability, NHIQ's ROE is +0.35%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, NHIQ is less volatile compared to ACHKF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MDNWF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MDNWF has a market cap of 517288.00. Regarding current trading prices, NHIQ is priced at $0.00, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, NHIQ's ROE is +0.35%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, NHIQ is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs NDATF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, NDATF has a market cap of 450469.00. Regarding current trading prices, NHIQ is priced at $0.00, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas NDATF's P/E ratio is -0.55. In terms of profitability, NHIQ's ROE is +0.35%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, NHIQ is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs LFCOF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, LFCOF has a market cap of 281984.00. Regarding current trading prices, NHIQ is priced at $0.00, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, NHIQ's ROE is +0.35%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, NHIQ is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs TSTTF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, TSTTF has a market cap of 190392.00. Regarding current trading prices, NHIQ is priced at $0.00, while TSTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas TSTTF's P/E ratio is -0.07. In terms of profitability, NHIQ's ROE is +0.35%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, NHIQ is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EWLL Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EWLL has a market cap of 185077.00. Regarding current trading prices, NHIQ is priced at $0.00, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EWLL's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ALDNF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ALDNF has a market cap of 160415.00. Regarding current trading prices, NHIQ is priced at $0.00, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ALDNF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs USPS Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, USPS has a market cap of 158503.00. Regarding current trading prices, NHIQ is priced at $0.00, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas USPS's P/E ratio is -1.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to USPS's ROE of N/A. Regarding short-term risk, NHIQ is more volatile compared to USPS. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs EMYSF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, EMYSF has a market cap of 151670.00. Regarding current trading prices, NHIQ is priced at $0.00, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas EMYSF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs NMXS Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, NMXS has a market cap of 116770.00. Regarding current trading prices, NHIQ is priced at $0.00, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas NMXS's P/E ratio is -0.31. In terms of profitability, NHIQ's ROE is +0.35%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, NHIQ is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs DSOL Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, DSOL has a market cap of 88891.00. Regarding current trading prices, NHIQ is priced at $0.00, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas DSOL's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, NHIQ is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PASO Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PASO has a market cap of 74059.00. Regarding current trading prices, NHIQ is priced at $0.00, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PASO's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to PASO's ROE of +6.20%. Regarding short-term risk, NHIQ is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ICCO Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ICCO has a market cap of 71654.00. Regarding current trading prices, NHIQ is priced at $0.00, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ICCO's P/E ratio is -0.40. In terms of profitability, NHIQ's ROE is +0.35%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, NHIQ is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs REFG Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, REFG has a market cap of 60838.00. Regarding current trading prices, NHIQ is priced at $0.00, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas REFG's P/E ratio is -0.01. In terms of profitability, NHIQ's ROE is +0.35%, compared to REFG's ROE of +0.01%. Regarding short-term risk, NHIQ is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SOFE Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SOFE has a market cap of 45131.00. Regarding current trading prices, NHIQ is priced at $0.00, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SOFE's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, NHIQ is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HDVY Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HDVY has a market cap of 41171.00. Regarding current trading prices, NHIQ is priced at $0.00, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HDVY's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs IGRW Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, IGRW has a market cap of 39815.00. Regarding current trading prices, NHIQ is priced at $0.00, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas IGRW's P/E ratio is -0.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, NHIQ is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs WMGR Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, WMGR has a market cap of 36250.00. Regarding current trading prices, NHIQ is priced at $0.00, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas WMGR's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to WMGR. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs SSYNF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, SSYNF has a market cap of 33293.00. Regarding current trading prices, NHIQ is priced at $0.00, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to SSYNF's ROE of N/A. Regarding short-term risk, NHIQ is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs RVRC Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, RVRC has a market cap of 31411.00. Regarding current trading prices, NHIQ is priced at $0.00, while RVRC trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas RVRC's P/E ratio is -0.09. In terms of profitability, NHIQ's ROE is +0.35%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, NHIQ is less volatile compared to RVRC. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs TTBLF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, TTBLF has a market cap of 26744.00. Regarding current trading prices, NHIQ is priced at $0.00, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, NHIQ's ROE is +0.35%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, NHIQ is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ORHB Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ORHB has a market cap of 25558.00. Regarding current trading prices, NHIQ is priced at $0.00, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ORHB's P/E ratio is -0.01. In terms of profitability, NHIQ's ROE is +0.35%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, NHIQ is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs NHEL Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, NHEL has a market cap of 16219.00. Regarding current trading prices, NHIQ is priced at $0.00, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas NHEL's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, NHIQ is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs FDBH Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, FDBH has a market cap of 15022.00. Regarding current trading prices, NHIQ is priced at $0.00, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas FDBH's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, NHIQ is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs HLTT Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, HLTT has a market cap of 10663.00. Regarding current trading prices, NHIQ is priced at $0.00, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas HLTT's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, NHIQ is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs MOSTQ Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, MOSTQ has a market cap of 8517.00. Regarding current trading prices, NHIQ is priced at $0.00, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas MOSTQ's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, NHIQ is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs AHGIF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, AHGIF has a market cap of 7789.00. Regarding current trading prices, NHIQ is priced at $0.00, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas AHGIF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, NHIQ is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs BBLNF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, BBLNF has a market cap of 2561.00. Regarding current trading prices, NHIQ is priced at $0.00, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas BBLNF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, NHIQ is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs PCYS Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, PCYS has a market cap of 1105.00. Regarding current trading prices, NHIQ is priced at $0.00, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas PCYS's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to PCYS's ROE of N/A. Regarding short-term risk, NHIQ is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs OLMM Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, OLMM has a market cap of 1005.00. Regarding current trading prices, NHIQ is priced at $0.00, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas OLMM's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ACNV Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ACNV has a market cap of 814.00. Regarding current trading prices, NHIQ is priced at $0.00, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ACNV's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to ACNV. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs ETAOF Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, ETAOF has a market cap of 512.00. Regarding current trading prices, NHIQ is priced at $0.00, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas ETAOF's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, NHIQ is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs LGBI Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, LGBI has a market cap of 50.00. Regarding current trading prices, NHIQ is priced at $0.00, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas LGBI's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, NHIQ is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for NHIQ.
NHIQ vs APYI Comparison
NHIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHIQ stands at 82414.00. In comparison, APYI has a market cap of 34.00. Regarding current trading prices, NHIQ is priced at $0.00, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHIQ currently has a P/E ratio of N/A, whereas APYI's P/E ratio is N/A. In terms of profitability, NHIQ's ROE is +0.35%, compared to APYI's ROE of -0.60%. Regarding short-term risk, NHIQ is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for NHIQ.